Quest Diagnostics Incorporated (NYSE:DGX) SVP Catherine T. Doherty sold 80,000 shares of the stock in a transaction on Monday, January 30th. They presently have a $90.00 target price on the stock, down from their prior target price of $103.00.
A number of analysts recently commented on DGX shares. FBR Capital has "Outperform" rating and $110 target. Mizuho reissued a buy rating and set a $90.00 target price (down from $103.00) on shares of Quest Diagnostics in a research report on Friday, April 14th. Deutsche Bank AG reiterated a "buy" rating and set a $108.00 target price on shares of Quest Diagnostics in a report on Wednesday, January 18th. Jefferies Group LLC restated a "hold" rating and issued a $96.00 price target on shares of Quest Diagnostics in a report on Thursday, March 16th.
Among 12 analysts covering Tesoro Logistics LP (NYSE:TLLP), 9 have Buy rating, 0 Sell and 3 Hold. American Registered Inv Advisor has invested 0.16% of its portfolio in Quest Diagnostics Inc (NYSE:DGX). The company's 50 day moving average is $98.31 and its 200-day moving average is $91.20. Advantus Capital invested in 13,925 shares or 0.03% of the stock. Quest Diagnostics has a 12 month low of $72.95 and a 12 month high of $100.00.
Currently, Quest Diagnostics has a Zacks Rank #2 (Buy) but that could change following its strong first quarter 2017 earnings report which has just released. The company reported $1.31 EPS for the quarter, topping the Zacks' consensus estimate of $1.27 by $0.04. The company earned $1.86 billion during the quarter, compared to analysts' expectations of $1.86 billion. At present, the Gross Margin for Quest Diagnostics Incorporated DGX Medical Laboratories & Research is moving around at 39.40% alongside a Profit Margin of 8.50%. Smith Asset Grp Incorporated Limited Partnership owns 6,260 shares for 0.01% of their portfolio. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.87 billion. Coldstream Mgmt Incorporated stated it has 5,520 shares or 0.08% of all its holdings. The ex-dividend date of this dividend was Monday, April 3rd. A higher P/B ratio of Quest Diagnostics Incorporated is signposting that the investors have either overvalued it, or that its accountants have undervalued it.
DGX's revenue has grown at an average annualized rate of about 0.3% during the past five years. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of USA & worldwide trademark & copyright laws. The stock of Quest Diagnostics Inc (NYSE:DGX) has "Neutral" rating given on Wednesday, August 31 by Mizuho. Following the transaction, the senior vice president now directly owns 119,321 shares in the company, valued at approximately $10,808,096.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Another trade for 45,000 shares valued at $4.16M was sold by PREVOZNIK MICHAEL E. The stock was sold at an average price of $97.39, for a total value of $42,851.60. The company expects diluted earnings per share to be in the range of $4.73 to $4.88 and expects diluted earnings per share to be in the range of $5.45 to $5.60 on adjusted basis. The disclosure for this sale can be found here. Cwm Ltd Company holds 0% or 200 shares. These holdings make up 95.24% of the company's outstanding shares. Consequently, investors will be able to grasp the rudimentary determinant of asset distribution and all kinds of risk-return parameters for stocks together with the stock mutual funds. Atria Investments LLC now owns 6,544 shares of the company's stock valued at $643,000 after buying an additional 3,498 shares in the last quarter. Norinchukin Bank The now owns 7,443 shares of the company's stock worth $630,000 after buying an additional 23 shares in the last quarter. Finally, Schroder Investment Management Group boosted its stake in Quest Diagnostics by 10.2% in the third quarter. Norinchukin Bank The raised its position in shares of Quest Diagnostics by 0.3% in the third quarter. BlackRock Fund Advisors now owns 3,088,078 shares of the company's stock worth $261,344,000 after buying an additional 28,019 shares in the last quarter.
The ROA of Quest Diagnostics Incorporated is now valued at 6.30% indicating how profitable the company is in regards to its total assets. The company's Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, gene-based and esoteric testing, and drugs-of-abuse testing, as well as anatomic pathology services, and related services and insights.
Browns Seek Options for 2017 Draft
Holding the first overall pick, the Browns are slated to take defensive end Myles Garrett out of Texas A&M. Of course, any comment at this time of year should be taken with a grain of salt.
United Airlines Condemned for Violently Removing Passenger
The United CEO had previously referred to Dao as a " disruptive and belligerent passenger " in an internal company communication. Three people got off the flight, but the fourth said he was a doctor and needed to get home to treat patients on Monday.
National Hockey League playoffs: Senators at Bruins Game 3
Boucher wasn't aware of the debris that was thrown to the ice following Monday's contest as he immediately headed down the tunnel. Miller exited Game 1 of the best-of-seven, first-round series after knocking knees with Senators defenseman Mark Borowiecki.